Loading clinical trials...
Loading clinical trials...
A Phase II Study of Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer.
Conditions
Interventions
sunitinib
Locations
1
South Korea
National Cancer Center, Korea
Goyang-si, Gyeonggi-do, South Korea
Start Date
March 1, 2008
Primary Completion Date
February 1, 2012
Completion Date
September 1, 2012
Last Updated
June 19, 2013
NCT06066138
NCT07486219
NCT07336732
NCT05198830
NCT05692635
NCT07485114
Lead Sponsor
National Cancer Center, Korea
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions